SKI Market

Indian Indices

Sensex

81,537.70 -769.67
( -0.94%)

Global Indices

Nasdaq

49,128.98 -276.04
(-0.56%)

Dow Jones

6,938.97 4.62
(0.07%)

Hang Seng

53,831.56 142.67
(0.27%)

Nikkei 225

10,138.52 -11.53
(-0.11%)

Forex

USD-INR

91.58 0.09
(0.10%)

EUR-INR

107.27 0.14
(0.13%)

GBP-INR

123.20 0.33
(0.27%)

JPY-INR

0.58 0.00
(-0.17%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Remus Pharmaceuticals Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

78788

INE0O5T01011

205.5515954

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

REMUS

39.16

773.38

EPS(TTM)

Face Value()

Div & Yield %

16.76

0.23

Back

Advik Capital reports consolidated net loss of Rs 20.87 crore in the December 2025 quarter

Jan 24,2026

Net loss of Advik Capital reported to Rs 20.87 crore in the quarter ended December 2025 as against net profit of Rs 7.35 crore during the previous quarter ended December 2024. Sales reported to Rs -2.83 crore in the quarter ended December 2025 as against Rs 12.80 crore during the previous quarter ended December 2024.

Particulars	Quarter Ended
	Dec. 2025	Dec. 2024	% Var.
Sales	-2.83	12.80	PL
OPM %	794.70	72.66	-
PBDT	-26.02	10.91	PL
PBT	-26.16	10.73	PL
NP	-20.87	7.35	PL

81,537.70 -769.67 ( -0.94%)

49,128.98 -276.04 (-0.56%)

6,938.97 4.62 (0.07%)

53,831.56 142.67 (0.27%)

10,138.52 -11.53 (-0.11%)

91.58 0.09 (0.10%)

107.27 0.14 (0.13%)

123.20 0.33 (0.27%)

0.58 0.00 (-0.17%)